Viability/apoptotic morphology MDA-MB-231 cells were cultured in a 12-well plate (1 105 cells/well) with 1 mL complete DMEM and were allowed to reach 70%80% confluence
They are not approved for human or veterinary consumption and must not be used to diagnose, treat, cure, or prevent any disease
The federal GLP-1 NAION litigation is moving forward, and the court has scheduled a Science Day for June 2, 2026
Niacin, at pharmacologic doses, has historically been used to modify lipid profiles, though current guidelines no longer routinely recommend it for cardiovascular risk reduction
Common side effects may include nausea, diarrhea, dry mouth, headache, sweating, tremor, sleepiness, insomnia, decreased appetite, and sexual side effects
The appetite suppression that makes GLP-1 drugs effective at driving weight loss also means you eat less food and less food means fewer nutrients coming in.*